Cargando…

Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases

Genetic testing usually helps physicians to determine possible genetic diseases in unborn babies, genetic disorders of patients and the carriers who might pass the mutant gene on to their children. They are performed on blood, tissues or other body fluids. In recent years, the screening tests and di...

Descripción completa

Detalles Bibliográficos
Autores principales: Dundar, Munis, Uzak, Asli Subasioglu, Erdogan, Murat, Akbarova, Yagut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405382/
https://www.ncbi.nlm.nih.gov/pubmed/23199148
http://dx.doi.org/10.1007/s13167-011-0080-3
_version_ 1782239125274886144
author Dundar, Munis
Uzak, Asli Subasioglu
Erdogan, Murat
Akbarova, Yagut
author_facet Dundar, Munis
Uzak, Asli Subasioglu
Erdogan, Murat
Akbarova, Yagut
author_sort Dundar, Munis
collection PubMed
description Genetic testing usually helps physicians to determine possible genetic diseases in unborn babies, genetic disorders of patients and the carriers who might pass the mutant gene on to their children. They are performed on blood, tissues or other body fluids. In recent years, the screening tests and diagnostic tests have improved quickly and, as a result, the risks of pregnancy can be determined more commonly and physicians can diagnose several genetic disorders in the prenatal period. Detecting the abnormalities in utero enables correct management of the pregnancy, prenatal and postnatal medical care, and it is also important for making well informed decisions about continuing or terminating a pregnancy. Besides the improvements of conventional invasive diagnostic tests, the discovery of circulating cell-free foetal nucleic acids in maternal plasma has developed a new point of view for non-invasive prenatal diagnosis recently.
format Online
Article
Text
id pubmed-3405382
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-34053822012-07-27 Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases Dundar, Munis Uzak, Asli Subasioglu Erdogan, Murat Akbarova, Yagut EPMA J Review Article Genetic testing usually helps physicians to determine possible genetic diseases in unborn babies, genetic disorders of patients and the carriers who might pass the mutant gene on to their children. They are performed on blood, tissues or other body fluids. In recent years, the screening tests and diagnostic tests have improved quickly and, as a result, the risks of pregnancy can be determined more commonly and physicians can diagnose several genetic disorders in the prenatal period. Detecting the abnormalities in utero enables correct management of the pregnancy, prenatal and postnatal medical care, and it is also important for making well informed decisions about continuing or terminating a pregnancy. Besides the improvements of conventional invasive diagnostic tests, the discovery of circulating cell-free foetal nucleic acids in maternal plasma has developed a new point of view for non-invasive prenatal diagnosis recently. Springer Netherlands 2011-05-06 2011-06 /pmc/articles/PMC3405382/ /pubmed/23199148 http://dx.doi.org/10.1007/s13167-011-0080-3 Text en © European Association for Predictive, Preventive and Personalised Medicine 2011
spellingShingle Review Article
Dundar, Munis
Uzak, Asli Subasioglu
Erdogan, Murat
Akbarova, Yagut
Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases
title Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases
title_full Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases
title_fullStr Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases
title_full_unstemmed Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases
title_short Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases
title_sort prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3405382/
https://www.ncbi.nlm.nih.gov/pubmed/23199148
http://dx.doi.org/10.1007/s13167-011-0080-3
work_keys_str_mv AT dundarmunis predictionpreventionandpersonalisationofmedicationfortheprenatalperiodgeneticprenataltestsforbothrareandcommondiseases
AT uzakaslisubasioglu predictionpreventionandpersonalisationofmedicationfortheprenatalperiodgeneticprenataltestsforbothrareandcommondiseases
AT erdoganmurat predictionpreventionandpersonalisationofmedicationfortheprenatalperiodgeneticprenataltestsforbothrareandcommondiseases
AT akbarovayagut predictionpreventionandpersonalisationofmedicationfortheprenatalperiodgeneticprenataltestsforbothrareandcommondiseases